FDA Approves Lilly's Orforglipron; Trump Pharma Tariffs Loom
FDA approves Eli Lilly's oral obesity pill orforglipron (Foundayo) while Trump eyes 100% tariffs on imported pharmaceuticals and drug ingredients.
Obesity Treatment
3 articles tagged "Obesity Treatment"
FDA Approves High-Dose Wegovy 7.2mg for Obesity in 2026
The FDA approved high-dose semaglutide 7.2mg (Wegovy) for obesity, showing 18.7% mean weight loss in Phase 3 trials amid new Trump administration drug pricing agreements.
By Sarah Tanaka
Oral Obesity Pill Phase 2 Results & Cholesterol Guidelines 2026
Structure Therapeutics reports 16% weight loss in Phase 2 oral GLP-1 trial, plus GSK's Arexvy expansion and new cholesterol guideline updates.